SEARCH

SEARCH BY CITATION

Premature ovarian failure is a major risk factor for sexual dysfunction in women who receive treatment for premenopausal breast cancer. Women should be counseled on prevention of vulvovaginal dryness and atrophy when chemotherapy is initiated.